Mike Haney: So people may have heard, just on this physiology side, the word agonist GLP-1 agonist
CXCL9, CXCL10 and CXCL11 are interferon-inducible angiostatic chemokines that can directly inhibit angiogenesis by binding CXCR3 on endothelial cells [284,285,286]
Concurrent medications should be considered, particularly for patients taking multiple injectable medications
It helps signal fullness, supports insulin release, slows stomach emptying, and helps regulate blood sugar
The combination of the medication and preexisting gastroparesis symptoms could exacerbate nausea and vomiting. I dont recommend people who have a history of an eating disorder take GLP-1 drugs unless they absolutely need treatment, says Sue Decotiis, MD, triple board-certified physician in New York City
Asano et al